Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Patient-Reported Urinary Incontinence and Erectile Dysfunction Following Radical Prostatectomy: Results from the European Prostate Centre Innsbruck.

Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W.

Urol Int. 2015 Jan 31. [Epub ahead of print]

PMID:
25662301
2.

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.

Oostvogels AJ, DE Wit GA, Jahn B, Cassini A, Colzani E, DE Waure C, Kretzschmar ME, Siebert U, Mühlberger N, Mangen MJ.

Epidemiol Infect. 2014 Dec 12:1-12. [Epub ahead of print]

PMID:
25499823
3.

The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases.

Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Mühlberger N, van Lier A, Haagsma JA, Brooke RJ, Lai T, de Waure C, Kramarz P, Kretzschmar ME; BCoDE consortium.

PLoS One. 2013 Nov 20;8(11):e79740. doi: 10.1371/journal.pone.0079740. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/caf33818-3453-4e30-b307-7526427b09b7.

4.

Predicted effects of treatment for HCV infection vary among European countries.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P.

Gastroenterology. 2012 Oct;143(4):974-85.e14. doi: 10.1053/j.gastro.2012.05.054. Epub 2012 Aug 2.

PMID:
22863764
5.

Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.

Bouchaud O, Mühlberger N, Parola P, Calleri G, Matteelli A, Peyerl-Hoffmann G, Méchaï F, Gautret P, Clerinx J, Kremsner PG, Jelinek T, Kaiser A, Beltrame A, Schmid ML, Kern P, Probst M, Bartoloni A, Weinke T, Grobusch MP.

Malar J. 2012 Jun 22;11:212. doi: 10.1186/1475-2875-11-212.

6.

Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U.

Eur J Cancer. 2011 Jul;47(11):1633-46. doi: 10.1016/j.ejca.2011.03.006. Epub 2011 Apr 7.

PMID:
21482103
7.

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U.

GMS Health Technol Assess. 2010 Apr 27;6:Doc05. doi: 10.3205/hta000083.

8.

Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm.

Schmidt T, Mühlberger N, Chemelli-Steingruber IE, Strasak A, Kofler B, Chemelli A, Siebert U.

Rofo. 2010 Jul;182(7):573-80. doi: 10.1055/s-0029-1245140. Epub 2010 Jun 18. Review.

PMID:
20563953
9.

Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

J Viral Hepat. 2010 Jan;17(1):34-50. doi: 10.1111/j.1365-2893.2009.01147.x. Epub 2009 Jul 28.

PMID:
19656290
10.

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpub/ckp001. Epub 2009 Feb 5. Review.

11.

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.

Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U.

BMC Public Health. 2009 Jan 22;9:34. doi: 10.1186/1471-2458-9-34. Review.

12.

Market uptake of new antiviral drugs for the treatment of hepatitis C.

Lettmeier B, Mühlberger N, Schwarzer R, Sroczynski G, Wright D, Zeuzem S, Siebert U.

J Hepatol. 2008 Oct;49(4):528-36. doi: 10.1016/j.jhep.2008.04.021. Epub 2008 Jun 2.

PMID:
18682313
13.

Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health.

Mühlberger N, Sroczynski G, Esteban E, Mittendorf T, Miksad RA, Siebert U.

Int J Technol Assess Health Care. 2008 Spring;24(2):184-92. doi: 10.1017/S0266462308080264. Review.

PMID:
18400122
14.

The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?

Behrens RH, Carroll B, Beran J, Bouchaud O, Hellgren U, Hatz C, Jelinek T, Legros F, Mühlberger N, Myrvang B, Siikamäki H, Visser L; TropNetEurop.

Malar J. 2007 Aug 23;6:114.

15.

Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjørup I, Lopez-Velez R, Clerinx J, Peyerl-Hoffmann G, Sundøy A, Genton B, Kern P, Calleri G, de Górgolas M, Mühlberger N, Jelinek T; European Network on Surveillance of Imported Infectious Diseases.

J Infect Dis. 2007 Apr 15;195(8):1089-96. Epub 2007 Mar 2.

16.

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical.

Mittendorf T, Nocon M, Roll S, Mühlberger N, Sroczynski G, Siebert U, Willich SN, von der Schulenburg JM.

GMS Health Technol Assess. 2007 Sep 4;3:Doc08.

17.

Epidemiological and clinical features of travel-associated cryptosporidiosis.

Weitzel T, Wichmann O, Mühlberger N, Reuter B, Hoof HD, Jelinek T.

Clin Microbiol Infect. 2006 Sep;12(9):921-4.

18.

Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent.

Behrens RH, Bisoffi Z, Björkman A, Gascon J, Hatz C, Jelinek T, Legros F, Mühlberger N, Voltersvik P; TropNetEurop.

Malar J. 2006 Feb 1;5:7.

19.

[Molecular epidemiological surveillance of markers for antimalarial drugs in Plasmodium falciparum isolates imported to Barcelona, Spain].

Gascón J, Mayor A, Mühlberger N, Peyerl-Hoffmann G, Oliveira I, Dobaño C, Jelinek T, Corachan M.

Med Clin (Barc). 2005 Sep 10;125(8):286-9. Spanish.

PMID:
16159551
20.

Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network.

Weitzel T, Mühlberger N, Jelinek T, Schunk M, Ehrhardt S, Bogdan C, Arasteh K, Schneider T, Kern WV, Fätkenheuer G, Boecken G, Zoller T, Probst M, Peters M, Weinke T, Gfrörer S, Klinker H, Holthoff-Stich ML; Surveillance Importierter Infektionen in Deutschland (SIMPID) Surveillance Network.

Eur J Clin Microbiol Infect Dis. 2005 Jul;24(7):471-6.

PMID:
15997368
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk